STEMPRO mesenchymal stem cells (MSC) serum free media (SFM) is a first of its kind product that overcomes many challenges in MSC culture.
In addition to launching Stempro MSC SFM, Invitrogen has launched two other products – Stempro Adipogenesis and Stempro Osteogenesis differentiation kits. These kits contain media and specific supplements that can induce MSCs to follow the developmental path to either bone cells or fat cells, allowing researchers to study how MSCs differentiate into multiple tissue types.
Joydeep Goswami, vice president of stem cells and regenerative medicine for Invitrogen, said: “Stempro MSC SFM satisfies a keen need for these researchers and will allow therapeutics companies to provide more robust products to patients who need them.”